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Abstract  
BACKGROUND: Hypercalcemia is a common manifestation in clinical practice and occurs as a 
result of primary hyperparathyroidism, malignancy, milk-alkali syndrome, hyper or hypothyroidism, 
sarcoidosis and other known and unknown causes. Patients with milk-alkali syndrome typically are 
presented with renal failure, hypercalcemia, and metabolic alkalosis caused by the ingestion of 
calcium and absorbable alkali. This syndrome is caused by high intake of milk and sodium 
bicarbonate. 
CASE PRESENTATION: We present a 28-year old male admitted to hospital with a one-month 
history of nausea, vomiting, epigastric pain, increased blood pressure and worsening of renal 
function with hypercalcemia. His serum PTH level was almost undetectable; he had mild alkalosis, 
renal failure with eGFR of 42 ml/min, anemia, hypertension and abnormal ECG with shortened QT 
interval and ST elevation in V1-V4. He had a positive medical history for calcium-containing 
antacids intake and after ruling out primary hyperparathyroidism, malignancy, multiple myelomas, 
sarcoidosis, and thyroid dysfunction, it seemed plausible to diagnose him as having the milk-alkali 
syndrome. 
CONCLUSION: Although milk-alkali syndrome currently may be more probably a result of calcium 
and vitamin D intake in postmenopausal women, or in elderly men with reduced kidney function 
taking calcium-containing medications, one should not exclude the possibility of its appearance in 
younger patients taking calcium-containing medications and consider it a serious condition taking 
into account its possibility of inducing renal insufficiency. 
 
 
 
 
Introduction 
 
Hypercalcemia is a common manifestation in 
clinical practice and occurs as a result of various 
underlying conditions. The reference range of serum 
calcium is maintained by a complex interplay of 3 
major hormones, parathyroid hormone (PTH), 1,25- 
dihydroxy vitamin D (calcitriol) and calcitonin. They act 
primarily on bone, kidney and small intestine [1]. 
Primary hyperparathyroidism and malignancy account 
for approximately 80-90% of all hypercalcemic 
patients. Other causes of hypercalcemia include 
hypervitaminosis D, Milk-alkali syndrome, 
hyperthyroidism, hypothyroidism, Addison’s disease, 
sarcoidosis, thiazides, renal transplant or dialysis and 
unknown causes [2].  
Patients with milk-alkali syndrome typically 
present with renal failure, hypercalcemia, and 
metabolic alkalosis caused by the ingestion of calcium 
and absorbable alkali. This syndrome is caused by 
high intake of milk and sodium bicarbonate, which 
was used for peptic ulcer treatment before the advent 
of histamine blockers and proton-pump inhibitors. 
Recently, use of calcium carbonate and vitamin D has 
increased among the elderly to prevent increases in 
osteoporosis, which in turn, may lead to 
hypercalcemia in the frame of milk-alkali syndrome 
[3]. 
We report the case of a man who presented 
with severe hypercalcemia, renal failure, and 
abdominal complaints. 
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Case presentation 
 
A 28-year-old male was admitted to hospital 
with a one-month history of nausea, vomiting, the 
epigastric pain increased blood pressure and 
worsening of renal function with hypercalcemia. He 
was diagnosed in the outpatient setting as having 
gastroesophageal reflux disease with biliary 
regurgitation and, therefore, was given high doses of 
calcium containing antacids. A therapy with calcium 
antagonists was also initiated because of increased 
levels of blood pressure.  
Upon admission, he was well oriented, with 
slightly yellowish skin color, his blood pressure was 
160/100 mmHg, his heart rate was 96/min. The rest of 
the physical examination was normal. He was a non-
smoker and his past medical history was normal. The 
following initial analyzes have been performed: 
Table 1: Pertinent laboratory values at admission 
Test Patient Values Reference Ranges 
Calcium 3.6 2.1-2.55 mmol/l 
Ca
2+ 
Albumin 
1.86 
41 
1.3-1.6 mmol/l 
35-50 g/l 
Total protein 71 65-80 g/l 
WBC count 10.2 × 10
9
/L 4-9 × 10
9
/L 
Haemoglobin 8.7 14.0-18.0 g/dL 
Haematocrit 0.28 0.37-0.54 
ESR 38 mm/hr 4-10 mm/hr 
Sodium 138 mmol/L 135-145 mmol/L 
Potassium 3.4 mmol/L 3.8-5.5 mmol/L 
Chloride 93 mmol/L 99-108 mmol/L 
Bicarbonate 36 mmol/L 22-29 mmol/L 
Blood urea nitrogen 8.2 3-7.8 mmol/l 
Creatinine 233 45-109 µmol/L 
Phosphate 0.9 0.8-1.4 mmol/L 
Alkaline phosphatase 60 U/L 11-85 U/L 
Free T4 18.03 8.41-17.65 pmol/L 
PTH 2.4 15-65 pg/ml 
Bilirubin (total)                    25                        6.8-20.5 µmol/L 
Bilirubin indirect                    19                        5.1-13.6 µmol/L 
Urinary excretion of 
Proteins                                 0.68                                0.2  g/dU 
Uric acid                               539                              150-450 µmol/L 
________________________________________________________________________ 
 
The patient had severe hypercalcemia and 
anemia, renal insufficiency, metabolic alkalosis. 
Serum parathyroid hormone was almost undetectable. 
His lipids were normal, too and urine culture negative. 
All the available tumor markers were normal (CEA, 
AFP, CA 19-9, NSE, CYFRA 21-1, PSA, Ferritin). He 
was hepatitis B, C and HIV negative. Renal ultrasound 
was normal. Ultrasound of the parathyroid glands was 
normal. Computerized tomography of the abdomen 
showed normal findings. Bone biopsy showed 
osteoporosis and scattered zones with osteonecrosis. 
Renal biopsy showed tubulointerstitial lesions with 
calcium deposits in the interstitial tissue. Chest X-ray 
was also normal. Endoscopy of the upper 
gastrointestinal tract while hospitalized showed no 
pathologic changes. Beta-2 microglobulin, acid 
phosphatase, kappa and lambda light chains were 
normal. Coombs test and immunoelectrophoresis of 
proteins were negative. The calculated creatinine 
clearance at admission was 42 ml/min. The whole 
body Tc
99m 
MDP bone scan was normal, as well as 
the parathyroid glands Tc
99m 
MIBI scan. Cranial X-ray, 
as well as radiographs of hands and feet, was normal. 
He had mild metabolic alkalosis, and his ECG showed 
signs of hypercalcemia (shortened QT interval of 0.32 
sec and abnormal ST morphology in V2, V3 and V4) 
(Fig.1 and Fig. 2).  
 
Figure 1: ECG changes as a result of hypercalcaemia 
hypercalcaemia (V1-V3) 
 
The patient was hydrated with intravenous 
fluid, treated with bisphosphonates, corticosteroids 
and calcium antagonists for his elevated blood 
pressure. Antacids were stopped promptly after 
admission. He was also given vitamin B12 and folic 
acid upon the recommendation of a hematologist. The 
serum level of calcium decreased slowly to 2.6 mmol/l 
at the 43
d
 day after admission, and serum creatinine 
decreased to 154 µmol/l (calculated creatinine 
clearance 63.5 ml/min). 
 
Figure 2: ECG changes as a result of hypercalcaemia (V4-V6) 
 
After ruling out the differential diagnosis of 
multiple myelomas, other malignancies, primary 
hyperparathyroidism, hyperthyroidism or hypothyro-
idism, it seemed plausible that the cause of 
hypercalcemia might be the ingestion of calcium 
containing antacids prescribed by his primary 
physician for his gastroesophageal reflux disease. He 
was discharged from hospital after 45 days of 
hospitalization. 
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Discussion 
 
Calcium is the main component of bone 
skeleton and serves as the intracellular and 
extracellular messenger in numerous cellular events 
such as neuronal network, immune response, muscle 
contraction, and hormone secretion. Less than 1% of 
body calcium is in the extracellular space, maintaining 
the extracellular calcium concentration within a narrow 
range and is very important for calcium homeostasis. 
Ten percent of the plasma calcium is in a complex 
with anions like phosphate, citrate, and sulfate and 
only half of plasma calcium is in its free form (ionized 
form, iCa
2+
) and tightly regulated by hormones like 
parathyroid hormone (PTH), 1,25-dihydroxyvitamin 
D3(1,25(OH)2D3), calcitonin, and calcium itself. The 
kidney, intestine, and bone are the main target organs 
of these regulators, and the kidney plays a key role in 
the fine regulation of calcium excretion [4].  
Hypercalcemia is common in the clinical 
setting and occurs in conditions when the entry of 
calcium into the circulation is greater than the urine 
excretion or bone deposition, as is the case of 
accelerated bone resorption or excessive 
gastrointestinal absorption or decreased renal 
excretion. Primary hyperparathyroidism and 
malignancy are the most common causes of 
hypercalcemia [2]. Milk-alkali syndrome previously 
accounted for about 12% of cases and ranks the third 
among the causes of hypercalcemia in hospitalized 
patients [5]. But, after the advent of nonabsorbable 
antacids and later histamine-2 blockers, the incidence 
of this syndrome dropped to less than 1% of etiologies 
of hypercalcemia in the mid-seventies [6]. The 
pathophysiology of the milk-alkali syndrome is poorly 
understood, particularly because only some 
individuals are affected by excessive ingestion, but it 
has been suggested that they absorb more calcium 
than others. Patients who appear to be at high risk for 
milk-alkali syndrome include old age, volume 
depletion and medication that reduces glomerular 
filtration rate, such as angiotensin converting enzyme 
inhibitors, angiotensin receptor blockers or non-
steroidal anti-inflammatory agents. Hypercalcemia 
causes reduced glomerular filtration rate, increased 
sodium excretion and depletion of total body water, 
leading to increased bicarbonate reabsorption and 
metabolic alkalosis. Alkalosis enhances calcium 
reabsorption in the distal nephron, thus, aggravating 
the hypercalcemia [7]. 
The modern version of the milk-alkali 
syndrome is now known as a calcium-alkali syndrome. 
It is the third most common cause of hypercalcemia in 
a retrospective study at a single center, where many 
patients reported consuming less than 2 g of 
elemental calcium per day in the form of calcium 
carbonate [8]. Whereas the traditional milk-alkali 
syndrome affected younger male patients with peptic 
ulcer disease, the demographics have changed to 
post-menopausal women, solid organ transplant 
recipients, pregnant women, bulimic patients, and 
those on dialysis [9]. 
Our patient had high levels of serum calcium, 
as in malignancies, thus our primary aim was to rule 
out malignant diseases. His PTH levels were 
suppressed and almost undetectable, thus in the 
differential diagnosis primary hyperparathyroidism 
was not to be considered. He also, had normal thyroid 
function, no signs of hypervitaminosis D, no medical 
history of medications that can cause hypercalcemia, 
neither signs nor symptoms of sarcoidosis. As he had 
positive medical history on calcium containing 
antacids intake because of his gastroesophageal 
reflux, while being volume depleted for his vomiting, 
and having already mild metabolic alkalosis, it was 
plausible to make an association of his medical history 
and the presence of the milk-alkali syndrome. The 
patient had ECG signs of hypercalcemia, shortened 
QT interval and elevated ST segment in V1-V4, 
mimicking STEMI (ST elevation myocardial infarction). 
These ECG abnormalities have been seen in other 
patients, too [10, 11]. He developed transitory renal 
insufficiency, with a complete remission few months 
after discharge. All signs and symptoms disappeared, 
his blood pressure returned to normal, and he has 
regular nephrology controls for 10 years now, with all 
his laboratory data being normal. He takes no 
medication and is in perfectly well condition.  
In conclusion, although milk-alkali or calcium-
alkali syndrome currently may be more probably a 
result of calcium and vitamin D intake in 
postmenopausal women, or in elderly men with 
reduced kidney function taking calcium-containing 
medications, one should not exclude the possibility of 
its appearance in younger patients taking calcium-
containing medications and consider it a serious 
condition taking into account its possibility of inducing 
renal insufficiency.  
 
 
References 
1. Emmett M, Singh AK. Acid-base and electrolytes. In: Singh AK. 
eds. Educational Review Manual in Nephrology. PPG New York, 
2007: 1-50. 
2. Lafferty F. Differential diagnosis of hypercalcemia. JBMR. 1991; 
6(S2):S51-S59. 
http://dx.doi.org/10.1002/jbmr.5650061413 
PMid:1763670 
 
3. Yamagami K, Nakamura T, Kishida M, Hanioka Y, Nakamura T, 
Yamaguchi T, Nishijima M, Inoue T, Yoshioka K, Imanishi M. 
Pulmonary and gastric metastatic calcification due to milk-alkali 
syndrome: a case report. CEN Case rep. 2013; 2:209-214. 
http://dx.doi.org/10.1007/s13730-013-0066-1 
 
4. Jeon US. Kidney and calcium homeostasis. Electrolyte Blood 
Press. 2008;6:68–76. 
http://dx.doi.org/10.5049/EBP.2008.6.2.68 
PMid:24459525 PMCid:PMC3894479 
 
5. Beall DP, Scofield RH. Milk-alkali syndrome associated with 
calcium carbonate consumption. Report of 7 patients with  
Case Report 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  286                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
parathyroid hormone levels and an estimate of prevalence among 
patients hospitalized with hypercalcemia. Medicine (Baltimore). 
1995;74:89–96. 
http://dx.doi.org/10.1097/00005792-199503000-00004 
6. Jamieson MJ. Hypercalcaemia. Br Med J (Clin Res Ed). 
1985;290:378–382. 
http://dx.doi.org/10.1136/bmj.290.6465.378 
 
7. Felsenfeld AJ, Levine BS. Milk alkali syndrome and the 
dynamics of calcium homeostasis. Clin J Am Soc Nephrol. 
2006;1:641–654. 
http://dx.doi.org/10.2215/CJN.01451005 
PMid:17699269 
 
8. Picolos MK, Lavis VR, Orlander PR. Milk-alkali syndrome is a 
major cause of hypercalcaemia among non-end-stage renal 
disease (non-esrd) inpatients. Clin Endocrinol. 2005;63:566–576. 
http://dx.doi.org/10.1111/j.1365-2265.2005.02383.x 
PMid:16268810 
 
9. Patel AM, Adeseun GA, ldfarb S. Calcium-Alkali Syndrome in 
the Modern Era. Nutrients. 2013; 5(12): 4880–4893. 
http://dx.doi.org/10.3390/nu5124880 
PMid:24288027 PMCid:PMC3875933 
 
10. Gardner JD, Calkins JB, Garrison GE. ECG Diagnosis: The 
Effect of Ionized Serum Calcium Levels on Electrocardiogram. 
Perm J. 2014; 18(1): e119–e120. 
http://dx.doi.org/10.7812/TPP/13-025 
PMid:24626084 PMCid:PMC3951043 
 
11. Donovan J, Jackson M. Hypercalcaemia Mimicking STEMI on 
Electrocardiography. Case Reports in Medicine. 2010; Article ID 
563572. 
 
 
